Atrás
Precio Turn Therapeutics Inc (TTRX)
Gráfico del Precio de Acciones TTRX
TTRX Financiero
Turn Therapeutics Inc
$4.62
1.31%
$0.06
Al cierre: Jan 20, 16:00:00 GMT-5
$4.62
0%
$0
Mercado Previo: Jan 21, 08:17:59 GMT-5
Sin datos aúnFollow-Up Questions
¿Cuáles son los estados financieros clave de Turn Therapeutics Inc?
¿Cuáles son los ratios financieros clave para TTRX?
¿Cómo se desglosan los ingresos de Turn Therapeutics Inc por segmento o geografía?
¿Es rentable Turn Therapeutics Inc?
¿Tiene Turn Therapeutics Inc alguna deuda?
¿Cuántas acciones en circulación tiene Turn Therapeutics Inc?
Estadísticas clave
Cierre Anterior
$4.56
Precio de apertura
$4.56
Rango del día
$4.52 - $4.9
Rango de 52 semanas
$2.57 - $26.5
Volumen
49.1K
Volumen promedio
89.8K
EPS (TTM)
--
Rendimiento de dividendos
--
Cap. de mercado
$136.0M
¿Qué es TTRX?
Turn Therapeutics, Inc. focuses on solving massive health problems by eliminating diseases and strengthening health systems through powerful partnerships and operational research. The company is headquartered in Westlake Village, California. The company went IPO on 2025-10-08. Its patented mixing process-commercially referred to as PermaFusion-enables stable suspension of polar, water-soluble active pharmaceutical ingredients (APIs) in oil-based carriers without the use of emulsifiers. Its primary development programs focus on dermatological diseases, including moderate to severe eczema and onychomycosis. Its products and programs include GX-03/Hexagen for Wounds (Hexagen (K160872)), GX-03/Hexagen for Derm (AtopX (K171191)), Sterile Gauze Impregnated with GX-03/Hexagen (XEAL (K183681)), Sterile Collagen/Hexagen Powder (FleX Product), GX-03/Hexagen for Moderate-Severe Eczema, and GX-03/Hexagen for Onychomycosis. GX-03/Hexagen for Wounds (Hexagen (K160872)) is a medical device for treating wounds and burns. GX-03/Hexagen for Derm (AtopX (K171191)) is a medical device for managing dermatitis.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved